CRENOGIST (ARO-012): An ongoing STUDY FOR D842V MUTANT GIST

This is a Phase III clinical trial of crenolanib in patients with advanced or metastatic gastrointestinal stromal tumors (GIST) with a specific mutation (D842V) in the PDGFRA gene.
This study is currently recruiting at multiple center.


Links: